Thyrocare Technologies, 539871, THYROCARE Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

3,361.70
51.25
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

3,360.85
2.84%
6.71

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

12.49
5.50
2.11

EBITDA CAGR (%)

10 Years
5 Years
3 Years

5.20
-4.49
-6.48

PAT CAGR (%)

10 Years
5 Years
3 Years

2.13
-5.32
-17.16

P:E (Median)

8 Years
5 Years
3 Years

38.99
35.34
38.09

P:BV (Average)

8 Years
5 Years
3 Years

8.09
8.43
8.21

EV:EBITDA (Average)

8 Years
5 Years
3 Years

23.00
21.54
21.45

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var%
Net Sales 122.89 117.17 4.88% 136.29 125.23 8.83% 123.61 119.24 3.66% 124.82 123.33 1.21%
Expenses 92.36 91.26 1.21% 99.66 95.69 4.15% 90.49 85.44 5.91% 102.05 86.50 17.98%
EBITDA 30.53 25.91 17.83% 36.63 29.54 24.00% 33.12 33.80 -2.01% 22.77 36.83 -38.18%
EBIDTM 24.84% 22.11% 26.88% 23.59% 26.79% 28.35% 18.24% 29.86%
Other Income 2.09 1.27 64.57% 1.82 1.16 56.90% 0.46 0.89 -48.31% 2.07 1.70 21.76%
Interest 0.96 0.59 62.71% 1.02 0.51 100.00% 0.80 0.55 45.45% 0.60 0.58 3.45%
Depreciation 10.90 9.01 20.98% 9.30 8.07 15.24% 8.51 7.58 12.27% 9.42 8.57 9.92%
PBT 20.76 17.58 18.09% 28.13 22.12 27.17% 24.27 26.56 -8.62% 14.82 29.38 -49.56%
Tax 5.87 4.95 18.59% 7.84 7.82 0.26% 7.54 6.44 17.08% 4.89 9.03 -45.85%
PAT 14.89 12.63 17.89% 20.29 14.30 41.89% 16.73 20.12 -16.85% 9.93 20.35 -51.20%
PATM 12.12% 10.78% 14.89% 11.42% 13.53% 16.87% 7.96% 16.50%
EPS 2.81 2.38 18.07% 3.83 2.70 41.85% 3.16 3.80 -16.84% 1.87 3.84 -51.30%

Description Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var%
Net Sales 134.74 128.03 5.24% 148.00 134.97 9.65% 134.89 127.79 5.56% 135.88 130.56 4.07%
Expenses 103.15 100.17 2.97% 110.48 103.39 6.86% 100.38 91.87 9.26% 111.19 92.97 19.60%
EBITDA 31.59 27.86 13.39% 37.52 31.58 18.81% 34.51 35.92 -3.93% 24.69 37.59 -34.32%
EBIDTM 23.45% 21.76% 25.35% 23.40% 25.58% 28.11% 18.17% 28.79%
Other Income 2.73 2.10 30.00% 2.17 1.62 33.95% 0.98 1.00 -2.00% 3.70 2.15 72.09%
Interest 1.07 0.58 84.48% 1.13 0.54 109.26% 0.88 0.56 57.14% 0.67 0.57 17.54%
Depreciation 13.47 10.15 32.71% 10.65 9.15 16.39% 9.83 8.61 14.17% 10.80 9.67 11.69%
PBT 19.78 19.23 2.86% 27.91 23.51 18.72% 24.78 27.75 -10.70% 16.92 29.50 -42.64%
Tax 5.17 5.02 2.99% 7.94 8.18 -2.93% 7.65 6.28 21.82% 4.75 8.78 -45.90%
PAT 14.61 14.21 2.81% 19.97 15.33 30.27% 17.13 21.47 -20.21% 12.17 20.72 -41.26%
PATM 10.84% 11.10% 13.49% 11.36% 12.70% 16.80% 8.96% 15.87%
EPS 2.90 2.78 4.32% 3.84 2.92 31.51% 3.27 4.11 -20.44% 2.38 4.02 -40.80%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Description TTM Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Net Sales 507.61 486.46 561.53 474.27 401.06 370.28 331.79 297.53 235.13 180.08 149.98 Net Sales Growth 4.67% -13.37% 18.40% 18.25% 8.31% 11.60% 11.51% 26.54% 30.57% 20.07% Cost Of Goods Sold 153.17 156.37 165.23 160.55 112.34 105.32 90.85 77.95 66.98 55.23 42.51 Gross Profit 354.44 330.09 396.30 313.72 288.72 264.96 240.94 219.58 168.15 124.85 107.47 GP Margin 69.83% 67.86% 70.58% 66.15% 71.99% 71.56% 72.62% 73.80% 71.51% 69.33% 71.66% Total Expenditure 384.56 372.16 330.00 303.53 233.29 222.14 192.79 182.63 139.99 106.32 81.14 Power & Fuel Cost - 8.56 7.00 6.43 6.33 5.70 4.83 4.65 3.73 3.59 2.61 % Of Sales - 1.76% 1.25% 1.36% 1.58% 1.54% 1.46% 1.56% 1.59% 1.99% 1.74% Employee Cost - 102.61 58.82 56.79 45.75 40.51 32.49 30.22 24.29 16.96 12.09 % Of Sales - 21.09% 10.47% 11.97% 11.41% 10.94% 9.79% 10.16% 10.33% 9.42% 8.06% Manufacturing Exp. - 14.55 10.03 23.19 23.19 5.81 14.12 16.63 14.07 4.08 3.65 % Of Sales - 2.99% 1.79% 4.89% 5.78% 1.57% 4.26% 5.59% 5.98% 2.27% 2.43% General & Admin Exp. - 77.17 73.23 49.56 37.77 60.64 45.42 49.52 30.25 24.88 19.98 % Of Sales - 15.86% 13.04% 10.45% 9.42% 16.38% 13.69% 16.64% 12.87% 13.82% 13.32% Selling & Distn. Exp. - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 % Of Sales - 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% Miscellaneous Exp. - 12.90 15.69 7.01 7.91 4.16 5.08 3.66 0.66 1.58 0.00 % Of Sales - 2.65% 2.79% 1.48% 1.97% 1.12% 1.53% 1.23% 0.28% 0.88% 0.19% EBITDA 123.05 114.30 231.53 170.74 167.77 148.14 139.00 114.90 95.14 73.76 68.84 EBITDA Margin 24.24% 23.50% 41.23% 36.00% 41.83% 40.01% 41.89% 38.62% 40.46% 40.96% 45.90% Other Income 6.44 5.39 7.40 12.28 9.42 13.66 23.63 11.41 5.20 7.70 6.58 Interest 3.38 4.54 3.08 0.66 1.32 0.47 0.40 0.43 0.54 0.29 0.16 Depreciation 38.13 34.08 28.47 21.08 19.54 14.47 12.08 11.69 11.35 10.71 6.36 PBT 87.98 81.07 207.38 161.28 156.33 146.86 150.15 114.18 88.46 70.46 68.89 Tax 26.14 24.10 55.33 41.51 32.68 51.63 51.93 40.08 30.00 23.58 22.74 Tax Rate 29.71% 29.73% 26.68% 25.74% 29.18% 35.16% 35.10% 46.20% 33.80% 32.64% 33.01% PAT 61.84 56.97 152.05 119.77 79.32 95.23 96.03 46.67 58.75 48.66 46.16 PAT before Minority Interest 61.84 56.97 152.05 119.77 79.32 95.23 96.03 46.67 58.75 48.66 46.16 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 12.18% 11.71% 27.08% 25.25% 19.78% 25.72% 28.94% 15.69% 24.99% 27.02% 30.78% PAT Growth -8.25% -62.53% 26.95% 51.00% -16.71% -0.83% 105.76% -20.56% 20.74% 5.42% EPS 11.67 10.75 28.69 22.60 14.97 17.97 18.12 8.81 11.08 9.18 8.71

Description TTM Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 553.51 526.67 588.86 494.62 434.26 402.91 356.32 304.39 240.97 182.96 Net Sales Growth 6.17% -10.56% 19.05% 13.90% 7.78% 13.08% 17.06% 26.32% 31.71% Cost Of Goods Sold 161.88 163.23 169.69 163.90 117.09 110.53 94.98 81.42 70.35 55.83 Gross Profit 391.63 363.44 419.17 330.72 317.17 292.38 261.34 222.96 170.61 127.13 GP Margin 70.75% 69.01% 71.18% 66.86% 73.04% 72.57% 73.34% 73.25% 70.80% 69.49% Total Expenditure 425.20 404.14 353.13 323.36 260.69 248.75 211.69 189.03 146.92 110.29 Power & Fuel Cost - 10.70 8.40 7.64 8.69 7.77 6.68 6.35 5.32 3.95 % Of Sales - 2.03% 1.43% 1.54% 2.00% 1.93% 1.87% 2.09% 2.21% 2.16% Employee Cost - 106.15 61.13 58.07 48.92 43.35 35.34 32.00 25.70 17.48 % Of Sales - 20.15% 10.38% 11.74% 11.27% 10.76% 9.92% 10.51% 10.67% 9.55% Manufacturing Exp. - 19.44 14.72 27.89 27.67 8.29 5.34 6.84 5.81 4.21 % Of Sales - 3.69% 2.50% 5.64% 6.37% 2.06% 1.50% 2.25% 2.41% 2.30% General & Admin Exp. - 91.90 83.69 58.28 49.31 74.33 63.70 58.42 37.60 27.22 % Of Sales - 17.45% 14.21% 11.78% 11.35% 18.45% 17.88% 19.19% 15.60% 14.88% Selling & Distn. Exp. - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 % Of Sales - 0% 0% 0% 0% 0% 0% 0% 0% 0% Miscellaneous Exp. - 12.72 15.50 7.58 9.01 4.48 5.65 3.98 2.13 1.60 % Of Sales - 2.42% 2.63% 1.53% 2.07% 1.11% 1.59% 1.31% 0.88% 0.87% EBITDA 128.31 122.53 235.73 171.26 173.57 154.16 144.63 115.36 94.05 72.67 EBITDA Margin 23.18% 23.27% 40.03% 34.62% 39.97% 38.26% 40.59% 37.90% 39.03% 39.72% Other Income 9.58 8.42 29.25 12.43 6.67 10.13 23.26 12.29 6.54 8.11 Interest 3.75 4.83 3.21 0.87 1.85 0.61 0.44 0.46 0.55 0.30 Depreciation 44.75 38.71 33.87 30.28 31.91 26.17 20.10 18.05 18.24 12.87 PBT 89.39 87.41 227.90 152.54 146.48 137.51 147.35 109.14 81.80 67.62 Tax 25.51 24.23 51.58 39.32 52.01 52.92 51.71 38.83 30.00 23.58 Tax Rate 28.54% 27.72% 22.63% 25.78% 37.18% 38.48% 35.62% 47.52% 36.67% 34.87% PAT 63.88 64.36 176.14 113.22 87.89 84.59 93.45 42.88 51.80 45.22 PAT before Minority Interest 64.66 64.36 176.14 113.22 87.89 84.59 93.45 42.88 51.80 44.04 Minority Interest 0.78 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.18 PAT Margin 11.54% 12.22% 29.91% 22.89% 20.24% 20.99% 26.23% 14.09% 21.50% 24.72% PAT Growth -10.94% -63.46% 55.57% 28.82% 3.90% -9.48% 117.93% -17.22% 14.55% EPS 12.05 12.14 33.23 21.36 16.58 15.96 17.63 8.09 9.77 8.53

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Shareholder's Funds 521.04 520.70 445.46 378.23 455.78 453.88 417.98 375.38 279.19 206.26 Share Capital 52.93 52.90 52.87 52.84 52.80 53.72 53.72 53.72 50.54 10.92 Total Reserves 463.60 464.37 389.66 321.67 399.10 397.35 359.22 319.07 227.84 195.34 Non-Current Liabilities -3.67 0.43 4.78 1.77 5.93 12.74 10.36 7.33 6.71 33.06 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 25.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 6.04 0.00 0.00 0.00 Long Term Provisions 3.17 0.17 13.44 7.88 6.49 5.14 4.34 4.33 1.98 1.54 Current Liabilities 147.03 211.03 62.69 50.75 24.52 18.33 15.78 29.19 6.50 6.41 Trade Payables 22.14 13.41 21.02 19.17 5.37 5.69 0.87 1.46 0.82 1.51 Other Current Liabilities 37.05 38.80 35.75 29.85 17.51 6.52 12.32 8.82 4.09 4.46 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 0.00 0.45 0.00 0.00 0.00 Short Term Provisions 87.84 158.82 5.92 1.73 1.64 6.12 2.14 18.92 1.59 0.43 Total Liabilities 664.40 732.16 512.93 430.75 486.23 484.95 444.12 411.90 292.40 245.73 Net Block 155.63 148.31 119.15 111.56 108.26 102.96 89.21 92.58 83.05 87.33 Gross Block 277.56 244.89 192.92 167.12 145.42 125.74 100.90 131.07 109.81 87.33 Accumulated Depreciation 121.93 96.58 73.77 55.56 37.16 22.78 11.69 38.49 26.76 0.00 Non Current Assets 355.20 350.40 330.43 317.10 374.22 347.20 290.47 295.64 192.29 116.98 Capital Work in Progress 0.82 2.15 8.28 3.87 1.28 0.00 2.13 1.36 5.50 6.43 Non Current Investment 172.75 170.34 170.34 170.34 214.67 214.67 194.67 196.29 98.77 17.61 Long Term Loans & Adv. 22.98 23.77 29.06 27.67 49.76 29.34 4.29 5.42 4.99 5.61 Other Non Current Assets 1.98 4.75 3.60 3.66 0.25 0.23 0.16 0.00 0.00 0.00 Current Assets 309.20 381.76 182.50 113.65 112.01 137.75 153.65 116.27 100.11 128.75 Current Investments 101.19 89.05 103.47 69.03 74.64 100.10 104.16 69.49 63.70 101.39 Inventories 27.05 24.22 22.16 18.49 15.56 16.47 13.76 9.89 7.05 6.29 Sundry Debtors 83.31 92.78 44.29 15.19 11.06 8.91 5.98 7.30 4.65 4.91 Cash & Bank 16.39 12.00 7.67 7.30 9.05 9.28 10.62 7.65 4.29 11.90 Other Current Assets 81.26 2.34 2.80 1.32 1.70 2.99 19.13 21.94 20.43 4.25 Short Term Loans & Adv. 78.32 161.37 2.11 2.32 0.65 1.34 14.17 6.62 6.32 3.97 Net Current Assets 162.17 170.73 119.81 62.90 87.49 119.42 137.87 87.07 93.61 122.34 Total Assets 664.40 732.16 512.93 430.75 486.23 484.95 444.12 411.91 292.40 245.73

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 534.30 526.57 427.28 366.65 435.12 443.29 407.81 365.61 276.37 Share Capital 52.93 52.90 52.87 52.84 52.79 53.72 53.69 53.72 50.54 Total Reserves 476.84 470.23 371.47 310.08 378.44 386.75 349.08 309.29 225.02 Non-Current Liabilities 148.69 105.98 17.79 20.51 13.87 10.18 8.61 10.10 8.67 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 2.50 2.50 0.00 7.25 0.00 0.00 Long Term Provisions 143.86 96.17 13.58 8.16 6.72 5.33 5.15 6.82 3.16 Current Liabilities 150.93 215.26 95.10 81.69 20.59 20.30 17.62 31.41 7.30 Trade Payables 23.99 16.53 25.01 21.86 7.51 6.59 1.30 2.02 0.84 Other Current Liabilities 39.03 39.86 64.13 58.07 11.41 7.51 14.13 10.40 4.82 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 87.91 158.87 5.96 1.76 1.67 6.20 2.19 18.98 1.65 Total Liabilities 834.84 847.81 540.17 468.85 469.58 473.77 434.04 407.12 328.35 Net Block 293.89 284.95 253.06 269.09 294.30 298.75 258.67 259.10 196.01 Gross Block 461.10 422.59 365.93 359.08 355.40 336.04 276.72 318.18 237.06 Accumulated Depreciation 167.21 137.64 112.87 89.99 61.10 37.29 18.05 59.07 41.05 Non Current Assets 488.07 427.05 299.73 316.60 333.56 331.67 284.51 272.71 217.68 Capital Work in Progress 1.61 2.95 8.28 4.93 1.47 0.00 17.45 1.39 5.55 Non Current Investment 22.10 20.92 21.10 21.17 20.66 20.00 0.00 1.61 1.61 Long Term Loans & Adv. 169.40 113.48 14.16 18.32 16.89 12.69 8.23 10.60 14.50 Other Non Current Assets 1.07 4.75 3.13 3.09 0.24 0.23 0.16 0.00 0.00 Current Assets 346.77 420.76 240.44 152.25 136.02 142.10 149.53 134.40 110.67 Current Investments 122.30 125.21 104.49 69.03 74.64 100.10 104.16 91.63 84.30 Inventories 27.67 24.53 23.36 20.62 18.08 17.05 14.50 10.72 7.37 Sundry Debtors 85.12 93.20 44.68 16.30 12.16 9.54 6.28 7.50 4.91 Cash & Bank 28.47 13.91 15.73 11.07 9.60 11.86 11.79 10.29 5.08 Other Current Assets 83.21 2.44 47.66 32.41 21.54 3.55 12.80 14.26 9.01 Short Term Loans & Adv. 80.10 161.47 4.52 2.82 1.66 1.87 7.56 6.85 6.61 Net Current Assets 195.84 205.50 145.34 70.56 115.43 121.80 131.91 103.00 103.37 Total Assets 834.84 847.81 540.17 468.85 469.58 473.77 434.04 407.11 328.35

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Cash From Operating Activity 120.02 105.68 111.07 136.33 96.56 111.52 89.28 66.88 36.23 46.24 PBT 81.07 207.38 161.28 156.33 146.86 147.96 86.74 88.76 72.23 68.89 Adjustment 63.40 38.05 14.16 15.76 8.98 0.38 37.76 10.14 2.96 1.89 Changes in Working Capital 4.25 -83.43 -20.78 8.49 2.19 11.17 4.84 -0.87 -16.14 -1.42 Cash after chg. in Working capital 148.72 162.00 154.66 180.58 158.03 159.51 129.34 98.03 59.05 69.37 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -28.70 -56.32 -43.59 -44.25 -61.47 -47.99 -40.06 -31.15 -22.82 -23.13 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -31.65 -12.32 -53.09 26.84 -3.30 -48.26 -39.66 -18.61 -20.52 -51.91 Net Fixed Assets -31.34 -45.84 -30.21 -24.29 -20.96 -22.71 29.40 -17.12 -21.55 -8.29 Net Investments -14.55 14.42 -34.44 49.94 25.46 -15.94 -33.05 -103.31 -43.47 -41.79 Others 14.24 19.10 11.56 1.19 -7.80 -9.61 -36.01 101.82 44.50 -1.83 Cash from Financing Activity -87.50 -86.91 -57.81 -162.65 -96.14 -64.73 -48.50 -44.96 -22.84 0.00 Net Cash Inflow / Outflow 0.87 6.45 0.17 0.52 -2.88 -1.47 1.11 3.31 -7.13 -5.67 Opening Cash & Equivalents 11.50 5.05 4.88 4.36 7.24 8.71 7.60 4.29 11.42 17.09 Closing Cash & Equivalent 12.37 11.50 5.05 4.88 4.36 7.24 8.71 7.60 4.29 11.42

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 129.31 113.41 114.73 167.88 100.31 107.03 89.57 67.80 34.46 PBT 87.41 227.90 152.54 146.48 137.40 144.99 81.67 81.80 67.62 Adjustment 64.57 21.49 23.05 32.13 24.17 8.78 42.79 17.06 6.50 Changes in Working Capital 5.79 -79.22 -17.65 33.78 -0.65 2.17 5.57 0.87 -16.86 Cash after chg. in Working capital 157.77 170.17 157.94 212.39 160.92 155.94 130.03 99.72 57.25 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -28.46 -56.76 -43.21 -44.51 -60.61 -48.91 -40.46 -31.92 -22.79 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -38.99 -23.57 -48.66 0.95 -11.59 -43.22 -41.52 -17.68 -17.96 Net Fixed Assets -31.34 -45.84 -30.21 -24.29 -20.96 -22.71 29.40 -17.12 Net Investments -14.55 14.42 -34.44 49.94 25.46 -15.94 -33.05 -103.31 Others 6.90 7.85 15.99 -24.70 -16.09 -4.57 -37.87 102.75 Cash from Financing Activity -86.18 -89.41 -61.58 -164.78 -93.63 -63.87 -48.52 -44.96 -22.84 Net Cash Inflow / Outflow 4.14 0.43 4.49 4.05 -4.91 -0.06 -0.46 5.17 -6.34 Opening Cash & Equivalents 13.63 13.20 8.71 4.91 9.82 9.88 10.35 5.08 11.42 Closing Cash & Equivalent 17.77 13.63 13.20 8.96 4.91 9.82 9.88 10.24 5.08

Financial Ratios

Consolidated /

Standalone

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Book Value (Rs.) 97.59 97.78 83.70 70.88 85.59 83.97 76.86 69.39 55.08 47.23 ROA 8.16% 24.42% 25.38% 17.30% 19.61% 20.67% 10.90% 16.68% 18.08% 20.87% ROE 11.02% 31.68% 29.32% 19.20% 21.09% 22.23% 11.88% 18.05% 20.08% 25.20% ROCE 16.44% 43.57% 39.32% 27.17% 32.39% 33.78% 21.80% 27.28% 28.42% 33.17% Fixed Asset Turnover 1.86 2.57 2.63 2.57 2.73 2.93 2.57 1.95 1.83 1.85 Receivable days 66.06 44.55 22.89 11.94 9.84 8.19 8.14 9.27 9.68 10.03 Inventory Days 19.23 15.07 15.64 15.49 15.79 16.63 14.51 13.15 13.52 14.04 Payable days 41.49 38.03 45.68 21.61 11.73 7.76 2.99 3.46 4.69 4.66 Cash Conversion Cycle 43.81 21.59 -7.15 5.83 13.90 17.05 19.66 18.96 18.51 19.41 Total Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.02 0.00 0.00 0.12 Interest Cover 18.86 68.33 245.36 85.85 313.47 370.90 201.80 166.59 249.23 431.59

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 100.09 98.89 80.26 68.68 81.69 81.99 75.02 67.57 54.53 ROA 7.65% 25.38% 22.44% 18.73% 17.93% 20.59% 10.20% 14.09% 13.41% ROE 12.23% 37.18% 28.76% 22.13% 19.41% 22.16% 11.20% 16.22% 15.98% ROCE 17.61% 48.42% 38.52% 35.14% 31.36% 33.93% 21.05% 25.66% 24.57% Fixed Asset Turnover 1.19 1.49 1.36 1.22 1.17 1.16 1.02 0.87 0.77 Receivable days 61.79 42.73 22.50 11.96 9.83 8.10 8.26 9.40 9.80 Inventory Days 18.09 14.84 16.23 16.26 15.91 16.16 15.12 13.70 14.70 Payable days 45.30 44.68 52.19 45.78 13.10 8.88 4.17 4.18 3.23 Cash Conversion Cycle 34.58 12.90 -13.46 -17.55 12.64 15.38 19.21 18.92 21.27 Total Debt/Equity 0.00 0.00 0.00 0.01 0.01 0.00 0.02 0.00 0.00 Interest Cover 19.34 71.94 176.33 76.62 226.43 330.91 177.48 149.46 226.39

Top Investors:

nippon life india trustee ltd-a/c nippon india small cap fund

icici prudential india opportunities fund

theleme india master fund limited

llp

Annual Reports:

News Update:

Thyrocare Technologies completes acquisition of 100% stake in Think Health
28th Feb 2024, 09:30 AM

Consequently, Think Health has become wholly-owned subsidiary company of Thyrocare with effective from February 27, 2024
Read More
Thyrocare Tech. - Quarterly Results
1st Feb 2024, 17:04 PM

Read More
Thyrocare Technologies to acquire 100% stake in Think Health
1st Feb 2024, 16:56 PM

With this acquisition, the Company aims to enter into a new line of business of offering ECG testing services at home
Read More

Thyrocare Technologies Ltd.

Healthcare Services - Diagnostic

BSE: 539871 | NSE: THYROCARE

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update:

Thyrocare Technologies Ltd.

Healthcare Services - Diagnostic

BSE: 539871 | NSE: THYROCARE

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update: